These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 18807798)
1. Herceptin, Pharmac and the New Zealand District Health Boards: keeping abreast of the Code of Health and Disability Services Consumers' Rights? Graham K J Law Med; 2008 Aug; 16(1):103-8. PubMed ID: 18807798 [TBL] [Abstract][Full Text] [Related]
2. PHARMAC and Herceptin for early-stage breast cancer in New Zealand: Herceptin or deception? Rosevear M N Z Med J; 2006 Jun; 119(1235):U2014. PubMed ID: 16751832 [TBL] [Abstract][Full Text] [Related]
3. PHARMAC responds on Herceptin assumptions and decisions. Metcalfe S; Evans J N Z Med J; 2007 Aug; 120(1260):U2692. PubMed ID: 17726504 [No Abstract] [Full Text] [Related]
4. The hype over herceptin. Fitzpatrick J Nurs N Z; 2009 Mar; 15(2):4-5. PubMed ID: 19554708 [No Abstract] [Full Text] [Related]
5. PHARMAC's funding of 9 weeks Herceptin: many assumptions in a high-risk decision. Isaacs RJ; Frampton CM; Kuper-Hommel MJ N Z Med J; 2007 Aug; 120(1259):U2676. PubMed ID: 17721579 [No Abstract] [Full Text] [Related]
6. Skipping for herceptin funds. Harrison J Nurs N Z; 2007 Nov; 13(10):4. PubMed ID: 18084962 [No Abstract] [Full Text] [Related]
7. Raising money for herceptin. Harrison J Nurs N Z; 2007 Mar; 13(2):3. PubMed ID: 17429882 [No Abstract] [Full Text] [Related]
8. How much will Herceptin really cost? Balancing local and national priorities is not new. Dillon A; Littlejohns P BMJ; 2006 Dec; 333(7580):1219; discussion 1219-20. PubMed ID: 17158393 [No Abstract] [Full Text] [Related]
9. Roche responds to the 'Herceptin or deception' article. Petersen S N Z Med J; 2006 Jul; 119(1237):U2069; author reply U2069. PubMed ID: 16862210 [No Abstract] [Full Text] [Related]
11. How much will Herceptin really cost? The money is already there. Minhas R BMJ; 2006 Dec; 333(7580):1219; discussion 1219-20. PubMed ID: 17158392 [No Abstract] [Full Text] [Related]
12. Treatment provider's knowledge of the Health and Disability Commissioner's Code of Consumer Rights. Townshend PL; Sellman JD N Z Bioeth J; 2002 Jun; 3(2):16-21. PubMed ID: 15587494 [TBL] [Abstract][Full Text] [Related]
13. Breast Cancer Advocacy Coalition responds to the 'Herceptin or deception' article. ; Burgess EP N Z Med J; 2006 Jul; 119(1237):U2065; author reply U2065. PubMed ID: 16862207 [No Abstract] [Full Text] [Related]
14. Why have evidence if it's really money that matters? Walsh C Nurs N Z; 2008 Aug; 14(8):2. PubMed ID: 18822549 [No Abstract] [Full Text] [Related]
15. The debate about the funding of Herceptin: a case study of 'countervailing powers'. Gabe J; Chamberlain K; Norris P; Dew K; Madden H; Hodgetts D Soc Sci Med; 2012 Dec; 75(12):2353-61. PubMed ID: 23036988 [TBL] [Abstract][Full Text] [Related]
16. What counts as a health service? Weight loss companies through the looking glass of New Zealand's Code of Patients' Rights. Neill MJ J Law Med; 2013 Mar; 20(3):621-8. PubMed ID: 23600193 [TBL] [Abstract][Full Text] [Related]
17. Regulating for compassion? Paterson R J Law Med; 2010 Sep; 18(1):58-67. PubMed ID: 20977162 [TBL] [Abstract][Full Text] [Related]
18. Informed consent for people with diminished capacity to consent. Whyman RA; Rose D N Z Dent J; 2001 Dec; 97(430):137-9. PubMed ID: 11887664 [TBL] [Abstract][Full Text] [Related]
19. Setting the standard? New Zealand's approach to ensuring health and disability services of an appropriate standard. Godbold R; McCallin A J Law Med; 2005 Aug; 13(1):125-34. PubMed ID: 16117161 [TBL] [Abstract][Full Text] [Related]
20. Patient's right to information under the New Zealand Code of Rights. Mullen K J Law Med; 2015 Sep; 23(1):218-42. PubMed ID: 26554208 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]